Half-Matched stem cell transplant shows promise for blood cancer patients
NCT ID NCT03480360
First seen Feb 22, 2026 · Last updated Jun 13, 2026 · Updated 23 times
Summary
This study tested a stem cell transplant from a half-matched (haploidentical) donor in 21 adults with various blood cancers. The goal was to see how many patients survived and had successful engraftment at 100 days and one year. Researchers also looked at immune system recovery and side effects like graft-versus-host disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center
Lebanon, New Hampshire, 03756, United States
Conditions
Explore the condition pages connected to this study.